Acne fulminans: explosive systemic form of acne

Area of Science:

• Dermatology
• Internal Medicine

Background:

• Acne fulminans (AF) is a rare, severe variant of acne vulgaris.
• It is characterized by acute onset of painful, ulcerative nodules and systemic symptoms.
• AF predominantly affects adolescent males, with unknown etiology but potential links to androgens, autoimmunity, and genetics.

Purpose of the Study:

• To summarize the key features, diagnostic challenges, and treatment strategies for Acne Fulminans.
• To highlight the aggressive nature of AF and its associated systemic manifestations.
• To emphasize the importance of a combined treatment approach for optimal outcomes.

Main Methods:

• Literature review of existing studies on Acne Fulminans.
• Analysis of clinical presentation, laboratory findings, and treatment responses.
• Synthesis of current therapeutic recommendations.

Main Results:

• AF presents with destructive inflammatory nodules on the face, chest, and back.
• Systemic symptoms include fever, weight loss, and musculoskeletal pain, with laboratory findings of leukocytosis and elevated ESR.
• Traditional acne treatments are often ineffective, necessitating aggressive combined therapy.

Conclusions:

• Acne fulminans requires aggressive treatment with oral steroids and isotretinoin for at least 3-5 months to prevent recurrence.
• While prognosis is good with appropriate management, residual scarring from inflammatory nodules is common.
• Further research into the etiology of AF may lead to more targeted therapies.